32 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35356240 | Inhibition of Aldose Reductase by Novel Phytocompounds: A Heuristic Approach to Treating Diabetic Retinopathy. | 2022 | 2 |
2 | 35454074 | In Search of Differential Inhibitors of Aldose Reductase. | 2022 Mar 22 | 1 |
3 | 33109031 | Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions. | 2021 | 2 |
4 | 33494154 | Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems. | 2021 Jan 21 | 1 |
5 | 34066081 | Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. | 2021 May 12 | 2 |
6 | 34279787 | Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. | 2021 Jul | 1 |
7 | 34314916 | Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation. | 2021 Oct | 2 |
8 | 34677370 | Physiological and Pathological Roles of Aldose Reductase. | 2021 Sep 27 | 2 |
9 | 34768205 | Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase. | 2021 Dec | 2 |
10 | 32463711 | Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme: in vitro and in silico study. | 2020 May 28 | 2 |
11 | 32602375 | Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications. | 2020 Jul | 2 |
12 | 32628753 | Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway. | 2020 Sep 24 | 1 |
13 | 32640594 | Aldose Reductase Differential Inhibitors in Green Tea. | 2020 Jul 6 | 2 |
14 | 33069193 | Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review. | 2020 | 2 |
15 | 33158254 | (5-Hydroxy-4-oxo-2-styryl-4H-pyridin-1-yl)-acetic Acid Derivatives as Multifunctional Aldose Reductase Inhibitors. | 2020 Nov 4 | 2 |
16 | 33374137 | Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy Collateral Glucose-Utilizing Pathways in Diabetic Polyneuropathy. | 2020 Dec 24 | 1 |
17 | 31636082 | Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. | 2019 Nov 11 | 1 |
18 | 31723418 | Human aldose reductase unfolds through an intermediate. | 2019 | 1 |
19 | 29190815 | Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion. | 2017 | 1 |
20 | 19383984 | Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway. | 2009 Jul 3 | 1 |
21 | 19480738 | Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway. | 2009 Jun 1 | 4 |
22 | 20021424 | Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies. | 2008 Jan | 1 |
23 | 16297625 | Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors. | 2006 Feb | 1 |
24 | 14751239 | Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: role of AOP2. | 2004 Feb 20 | 2 |
25 | 12604218 | Up-regulation of aldose reductase by the substrate, methylglyoxal. | 2003 Feb 1 | 3 |
26 | 12615520 | Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy. | 2003 Apr | 2 |
27 | 11302779 | Natural therapies for ocular disorders, part two: cataracts and glaucoma. | 2001 Apr | 1 |
28 | 11862253 | The Effect of Urinary pH and Flow Rate on the Renal Elimination of Zopolrestat and Zopolrestat Glucuronide in Humans. | 1996 Mar | 1 |
29 | 8330752 | Peripheral nerve protein glycation and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS. | 1993 Jan-Feb | 1 |
30 | 1410879 | [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors]. | 1992 Jan-Feb | 1 |
31 | 2115448 | A thirty year journey in the polyol pathway. | 1990 Jun | 2 |
32 | 6086432 | Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. | 1984 Aug | 1 |